#pharma #ipo
πΊπΈ #ATEA PHARMACEUTICALS
β Stage: IPO
β Type: Equity
β Invest: $253M
β Valuation: $2 000M
β Revenue (1H2020): $0M
β EBIT (1H2020): $-14M
β Net Income (1H2020): $-14M
β Net Debt (1H2020): $0M
β Total Addressable Market (TAM): $40 000M
β Oversubscribed: Medium
(source: IPO Boutique)
β Analyst rating: Neutral
(source: IPO Boutique)
β Upside: 36%
@freenewspaper
πΊπΈ #ATEA PHARMACEUTICALS
β Stage: IPO
β Type: Equity
β Invest: $253M
β Valuation: $2 000M
β Revenue (1H2020): $0M
β EBIT (1H2020): $-14M
β Net Income (1H2020): $-14M
β Net Debt (1H2020): $0M
β Total Addressable Market (TAM): $40 000M
β Oversubscribed: Medium
(source: IPO Boutique)
β Analyst rating: Neutral
(source: IPO Boutique)
β Upside: 36%
@freenewspaper